Puffy hand syndrome due to drug addiction: a case–control study of the pathogenesis
Identifieur interne : 000500 ( France/Analysis ); précédent : 000499; suivant : 000501Puffy hand syndrome due to drug addiction: a case–control study of the pathogenesis
Auteurs : Valérie Andresz ; Nicolas Marcantoni ; Florence Binder ; Michel Velten ; Martine Alt ; Jean-Christophe Weber [France] ; Dominique Stephan [France]Source :
- Addiction [ 0965-2140 ] ; 2006-09.
Descripteurs français
- KwdFr :
- Antagonistes narcotiques (administration et posologie), Antagonistes narcotiques (effets indésirables), Buprénorphine (administration et posologie), Buprénorphine (effets indésirables), Facteurs de risque, Femelle, France, Humains, Lymphoedème (), Main, Mâle, Statistique non paramétrique, Syndrome, Toxicomanie intraveineuse (), Études cas-témoins.
- MESH :
- administration et posologie : Antagonistes narcotiques, Buprénorphine.
- effets indésirables : Antagonistes narcotiques, Buprénorphine.
- Facteurs de risque, Femelle, France, Humains, Lymphoedème, Main, Mâle, Statistique non paramétrique, Syndrome, Toxicomanie intraveineuse, Études cas-témoins.
- Wicri :
- geographic : France.
English descriptors
- KwdEn :
- Buprenorphine (administration & dosage), Buprenorphine (adverse effects), Case-Control Studies, Female, France, Hand, Humans, Lymphedema (chemically induced), Male, Narcotic Antagonists (administration & dosage), Narcotic Antagonists (adverse effects), Risk Factors, Statistics, Nonparametric, Substance Abuse, Intravenous (complications), Syndrome.
- MESH :
- chemical , administration & dosage : Buprenorphine, Narcotic Antagonists.
- chemical , adverse effects : Buprenorphine, Narcotic Antagonists.
- geographic : France.
- chemically induced : Lymphedema.
- complications : Substance Abuse, Intravenous.
- Case-Control Studies, Female, Hand, Humans, Male, Risk Factors, Statistics, Nonparametric, Syndrome.
Abstract
Aim We studied the pathogenesis of puffy hand syndrome of intravenous drug use. We hypothesized that injections of high‐dose sublingual buprenorphine, instead of the recommended sublingual administration, could play an important role in lymphatic obstruction and destruction.
Url:
DOI: 10.1111/j.1360-0443.2006.01521.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 007805
- to stream Istex, to step Curation: 007805
- to stream Istex, to step Checkpoint: 001646
- to stream PubMed, to step Corpus: 003907
- to stream PubMed, to step Curation: 003907
- to stream PubMed, to step Checkpoint: 003907
- to stream Ncbi, to step Merge: 002372
- to stream Ncbi, to step Curation: 002372
- to stream Ncbi, to step Checkpoint: 002372
- to stream Main, to step Merge: 007D55
- to stream Main, to step Curation: 007B62
- to stream Main, to step Exploration: 007B62
- to stream France, to step Extraction: 000500
Links to Exploration step
ISTEX:FF9CD93E8CB3CA280F1D191D78F26423A34E2C62Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Puffy hand syndrome due to drug addiction: a case–control study of the pathogenesis</title><author><name sortKey="Andresz, Valerie" sort="Andresz, Valerie" uniqKey="Andresz V" first="Valérie" last="Andresz">Valérie Andresz</name></author><author><name sortKey="Marcantoni, Nicolas" sort="Marcantoni, Nicolas" uniqKey="Marcantoni N" first="Nicolas" last="Marcantoni">Nicolas Marcantoni</name></author><author><name sortKey="Binder, Florence" sort="Binder, Florence" uniqKey="Binder F" first="Florence" last="Binder">Florence Binder</name></author><author><name sortKey="Velten, Michel" sort="Velten, Michel" uniqKey="Velten M" first="Michel" last="Velten">Michel Velten</name></author><author><name sortKey="Alt, Martine" sort="Alt, Martine" uniqKey="Alt M" first="Martine" last="Alt">Martine Alt</name></author><author><name sortKey="Weber, Jean Hristophe" sort="Weber, Jean Hristophe" uniqKey="Weber J" first="Jean-Christophe" last="Weber">Jean-Christophe Weber</name></author><author><name sortKey="Stephan, Dominique" sort="Stephan, Dominique" uniqKey="Stephan D" first="Dominique" last="Stephan">Dominique Stephan</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:FF9CD93E8CB3CA280F1D191D78F26423A34E2C62</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1111/j.1360-0443.2006.01521.x</idno><idno type="url">https://api.istex.fr/document/FF9CD93E8CB3CA280F1D191D78F26423A34E2C62/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">007805</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">007805</idno><idno type="wicri:Area/Istex/Curation">007805</idno><idno type="wicri:Area/Istex/Checkpoint">001646</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001646</idno><idno type="wicri:doubleKey">0965-2140:2006:Andresz V:puffy:hand:syndrome</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:16911735</idno><idno type="wicri:Area/PubMed/Corpus">003907</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003907</idno><idno type="wicri:Area/PubMed/Curation">003907</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003907</idno><idno type="wicri:Area/PubMed/Checkpoint">003907</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003907</idno><idno type="wicri:Area/Ncbi/Merge">002372</idno><idno type="wicri:Area/Ncbi/Curation">002372</idno><idno type="wicri:Area/Ncbi/Checkpoint">002372</idno><idno type="wicri:doubleKey">0965-2140:2006:Andresz V:puffy:hand:syndrome</idno><idno type="wicri:Area/Main/Merge">007D55</idno><idno type="wicri:Area/Main/Curation">007B62</idno><idno type="wicri:Area/Main/Exploration">007B62</idno><idno type="wicri:Area/France/Extraction">000500</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Puffy hand syndrome due to drug addiction: a case–control study of the pathogenesis</title><author><name sortKey="Andresz, Valerie" sort="Andresz, Valerie" uniqKey="Andresz V" first="Valérie" last="Andresz">Valérie Andresz</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Marcantoni, Nicolas" sort="Marcantoni, Nicolas" uniqKey="Marcantoni N" first="Nicolas" last="Marcantoni">Nicolas Marcantoni</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Binder, Florence" sort="Binder, Florence" uniqKey="Binder F" first="Florence" last="Binder">Florence Binder</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Velten, Michel" sort="Velten, Michel" uniqKey="Velten M" first="Michel" last="Velten">Michel Velten</name><affiliation><wicri:noCountry code="subField"></wicri:noCountry></affiliation></author><author><name sortKey="Alt, Martine" sort="Alt, Martine" uniqKey="Alt M" first="Martine" last="Alt">Martine Alt</name><affiliation><wicri:noCountry code="no comma">Centre de Pharmacovigilance</wicri:noCountry></affiliation></author><author><name sortKey="Weber, Jean Hristophe" sort="Weber, Jean Hristophe" uniqKey="Weber J" first="Jean-Christophe" last="Weber">Jean-Christophe Weber</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>and Médecine interne A, Hôpitaux Universitaires, Université Louis Pasteur, Strasbourg</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Alsace (région administrative)</region><settlement type="city">Strasbourg</settlement></placeName></affiliation></author><author><name sortKey="Stephan, Dominique" sort="Stephan, Dominique" uniqKey="Stephan D" first="Dominique" last="Stephan">Dominique Stephan</name><affiliation></affiliation><affiliation></affiliation><affiliation wicri:level="1"><country wicri:rule="url">France</country></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Addiction</title><title level="j" type="alt">ADDICTION</title><idno type="ISSN">0965-2140</idno><idno type="eISSN">1360-0443</idno><imprint><biblScope unit="vol">101</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="1347">1347</biblScope><biblScope unit="page" to="1351">1351</biblScope><biblScope unit="page-count">5</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2006-09">2006-09</date></imprint><idno type="ISSN">0965-2140</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0965-2140</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Buprenorphine (administration & dosage)</term><term>Buprenorphine (adverse effects)</term><term>Case-Control Studies</term><term>Female</term><term>France</term><term>Hand</term><term>Humans</term><term>Lymphedema (chemically induced)</term><term>Male</term><term>Narcotic Antagonists (administration & dosage)</term><term>Narcotic Antagonists (adverse effects)</term><term>Risk Factors</term><term>Statistics, Nonparametric</term><term>Substance Abuse, Intravenous (complications)</term><term>Syndrome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antagonistes narcotiques (administration et posologie)</term><term>Antagonistes narcotiques (effets indésirables)</term><term>Buprénorphine (administration et posologie)</term><term>Buprénorphine (effets indésirables)</term><term>Facteurs de risque</term><term>Femelle</term><term>France</term><term>Humains</term><term>Lymphoedème ()</term><term>Main</term><term>Mâle</term><term>Statistique non paramétrique</term><term>Syndrome</term><term>Toxicomanie intraveineuse ()</term><term>Études cas-témoins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Buprenorphine</term><term>Narcotic Antagonists</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Buprenorphine</term><term>Narcotic Antagonists</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>France</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antagonistes narcotiques</term><term>Buprénorphine</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Substance Abuse, Intravenous</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antagonistes narcotiques</term><term>Buprénorphine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Case-Control Studies</term><term>Female</term><term>Hand</term><term>Humans</term><term>Male</term><term>Risk Factors</term><term>Statistics, Nonparametric</term><term>Syndrome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Facteurs de risque</term><term>Femelle</term><term>France</term><term>Humains</term><term>Lymphoedème</term><term>Main</term><term>Mâle</term><term>Statistique non paramétrique</term><term>Syndrome</term><term>Toxicomanie intraveineuse</term><term>Études cas-témoins</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract">Aim We studied the pathogenesis of puffy hand syndrome of intravenous drug use. We hypothesized that injections of high‐dose sublingual buprenorphine, instead of the recommended sublingual administration, could play an important role in lymphatic obstruction and destruction.</div></front></TEI><affiliations><list><country><li>France</li></country><region><li>Alsace (région administrative)</li><li>Grand Est</li></region><settlement><li>Strasbourg</li></settlement></list><tree><noCountry><name sortKey="Alt, Martine" sort="Alt, Martine" uniqKey="Alt M" first="Martine" last="Alt">Martine Alt</name><name sortKey="Andresz, Valerie" sort="Andresz, Valerie" uniqKey="Andresz V" first="Valérie" last="Andresz">Valérie Andresz</name><name sortKey="Binder, Florence" sort="Binder, Florence" uniqKey="Binder F" first="Florence" last="Binder">Florence Binder</name><name sortKey="Marcantoni, Nicolas" sort="Marcantoni, Nicolas" uniqKey="Marcantoni N" first="Nicolas" last="Marcantoni">Nicolas Marcantoni</name><name sortKey="Velten, Michel" sort="Velten, Michel" uniqKey="Velten M" first="Michel" last="Velten">Michel Velten</name></noCountry><country name="France"><region name="Grand Est"><name sortKey="Weber, Jean Hristophe" sort="Weber, Jean Hristophe" uniqKey="Weber J" first="Jean-Christophe" last="Weber">Jean-Christophe Weber</name></region><name sortKey="Stephan, Dominique" sort="Stephan, Dominique" uniqKey="Stephan D" first="Dominique" last="Stephan">Dominique Stephan</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000500 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000500 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= France
|étape= Analysis
|type= RBID
|clé= ISTEX:FF9CD93E8CB3CA280F1D191D78F26423A34E2C62
|texte= Puffy hand syndrome due to drug addiction: a case–control study of the pathogenesis
}}
| This area was generated with Dilib version V0.6.31. |  |